用于癌症治疗的基于原药的双特异性抗体:进展和未来方向

Zhijuan Ai1,2, Bing Wang3, Yunlong Song4

  • 1The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.

Frontiers in immunology
|February 6, 2025
PubMed
概括

基于原药的双特异性抗体通过更精确地向瘤来增强癌症治疗. 本综述探讨了它们的激活机制和开发挑战,以改善临床使用.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K